Peripheral T-cell lymphomas constitute a heterogeneous populationof postthymic T-cell
malignancies. Characteristically, they present a varied phenotypic expression, which can be …

The unfavorable clinical evolution in indolent non-Hodgkin lymphomas suggests defective
control of neoplastic growth by the immune system. To address this issue, we evaluated …

We have isolated several T-cell clones from lymphocytes infiltrating a human major
histocompatibility class (MHC) II negative cutaneous T-cell lymphoma (CTCL). We describe …

Forty-one cases of T cell lymphoma were identified on the basis of morphology and the
expression of two or more T cell antigens with an absence of B cell markers. Mycosis …

Abstract The current World Health Organization (WHO) classification of hematopoietic
malignancies defines several types of mature T-cell leukemia including T-cell …

Tumors progression is under the control of a heterogeneous microenvironment composed of
immune cells, fibroblasts, blood and lymphatic vessels, in which T cells have been …

Peripheral T-cell lymphomas comprise a morphologically diverse group of malignant
lymphoproliferative disorders that arise from postthymic T cells Currently there exists no …

Recently, cell‐mediated immune response in malignant neoplasms has become the focus in
immunotherapy against cancer. However, in leukemia, most studies on the cytotoxic …

A murine monoclonal antibody (B2D) against a cultured pre-T acute lymphoblastic leukemia
(ALL) cell line THP-6 has been produced. The antibody reacted with seven out of eight …

Peripheral T-cell lymphomas (PTCLs) represent approximately 12% of all non-Hodgkin's
lymphomas in Western countries. They are quite heterogeneous as far as morphology and …